연구동향 분석

한국형 양극성 장애 약물치료 알고리듬 2022: 동반 신체질환

정명훈 박원명 우영섭 정종현 윤보현 서정석 양찬모 김원 이정구 심세훈 추일한 박성용 손인기 전덕인 김문두 2022년

논문상세정보
인용/피인용
' 한국형 양극성 장애 약물치료 알고리듬 2022: 동반 신체질환' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Bipolar disorder
  • Comorbid physical illnesses
  • KMAP-BP 2022.
  • pharmacotherapy
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
174 0

0.0%

' 한국형 양극성 장애 약물치료 알고리듬 2022: 동반 신체질환' 의 참고문헌

  • 한국형 양극성 장애 약물치료 알고리듬 2018 : 신체 질환이 동반되었을 경우
    송후림 [2018]
  • 한국형 양극성 장애 약물치료 알고리듬 2010: 다른 치료 지침들과의 비교
    윤보현 [2011]
  • 양극성 장애의 한국형 약물치료 알고리듬
    박원명 [2002]
  • 양극성 장애 환자의 의학적 공존질환：후향적 챠트 조사
    전덕인 [2007]
  • Ziprasidone and the corrected QT interval : a comprehensive summary of clinical data
    Camm AJ [2012]
  • Weight considerations in psychotropic drug prescribing and switching
    Hasnain M [2013]
  • Traumatic brain injury and mood disorders
    Robert S [2020]
  • The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 3:the clinical guidelines
  • Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials
    McGirr A [2016]
  • Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders
    Akiskal HS [2000]
  • Psychotropic drugs and liver disease : a critical review of pharmacokinetics and liver toxicity
  • Medical comorbidity in women and men with bipolar disorders : a population-based controlled study
    Carney CP [2006]
  • Medical comorbidity in a bipolar outpatient clinical population
    Beyer J [2005]
  • Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment
    Reynolds GP [2017]
  • Lamotrigine in the treatment of bipolar disorder
    Bhagwagar Z [2005]
  • Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision
  • From the EBM pyramid to the Greek temple : a new conceptual approach to guidelines as implementation tools in mental health
  • Expert opinion is necessary : Delphi panel methodology facilitates a scientific approach to consensus
    Hohmann E [2018]
  • Evidence-based guidelines for treating bipolar disorder : revised third edition recommendations from the British Association for Psychopharmacology
    Goodwin GM [2016]
  • Drug induced weight gain, an impediment to successful pharmacotherapy:focus on antipsychotics
    Baptista T [2004]
  • Comparison of the pharmacokinetics of lamotrigine in patients with chronic renal failure and healthy volunteers
    Wootton R [1997]
  • Comparison of the metabolic characteristics of newer second generation antipsychotics: brexpiprazole, lurasidone, asenapine, cariprazine, and iloperidone with olanzapine as a comparator
    Greger J [2021]
  • Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis
    Miura T [2014]
  • Canadian Network for Mood and Anxiety Treatments (CANMAT)and International Society for Bipolar Disorders (ISBD) 2018guidelines for the management of patients with bipolar disorder
    Yatham LN [2018]
  • Bipolar depression : a major unsolved challenge
  • Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences
    Carli M [2021]
  • Aripiprazole, a novel atypical antipsychotic drug
    Argo TR [2004]
  • Antiepileptic drugs
    Levy RH [1995]
  • Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a populationbased cohort study
    Hayes JF [2016]